Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Occurrence and Resolution of Anthracycline Cardiotoxicity and Impact on Treatment Outcomes Among Children Treated on the AAML1031 Clinical Trial: A Report from the Children's Oncology Group

Kelly D Getz, Lillian Sung, MD PhD, Robert B. Gerbing, Todd A. Alonzo, PhD, Yimei Li, PhD, Yuan-Shung V. Huang, MS, Kasey J Leger, MD MSc, Jessica A. Pollard, MD, Todd M Cooper, DO, Edward Anders Kolb, MD, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD

Blood (2019) 134 (Supplement_1): 331.

https://doi.org/10.1182/blood-2019-131227

Published: 2019

Journal Articles

To Study the Coagulation Profile Derangements in Metabolic Syndrome

Jitender Khunger, Monica Malhotra, MD, Nitin Kumar, MD, VPS Punia, MD, Mohan Agarwal, MD

Blood (2019) 134 (Supplement_1): 4959.

https://doi.org/10.1182/blood-2019-125048

Published: 2019

Journal Articles

Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center

David Hughes, PharmD, Frances Blevins, PA-C, Bhavesh Shah, RPh, Shayna Sarosiek, Adam Lerner, MD, John Mark Sloan, MD

Blood (2019) 134 (Supplement_1): 4912.

https://doi.org/10.1182/blood-2019-124740

Published: 2019

Journal Articles

Carfilzomib-Pomalidomide-Dexamethasone (KPD) in Relapsed/Refractory Multiple Myeloma Patients - an Institutional Retrospective Analysis

Pallavi Mehta, MD DM, Neha Yadav, BDS , MBA, Mohan Bhaarat, Sumeet Prakash Mirgh, MBBS, MDDM, Vishvdeep Khushoo, MBBS, MDDM, Shinto Francis Thekuddan, MBBS, MDDM, Narendra Agrawal, MD DM, Rayaz Ahmed, MDDM, Dinesh Bhurani, MD DM, FRCPA

Blood (2019) 134 (Supplement_1): 5572.

https://doi.org/10.1182/blood-2019-131674

Published: 2019

Journal Articles

Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study

Guillaume Moulis, MD PhD, Bérangère Baricault, Charlotta Ekstrand, Margaux Lafaurie, PharmD, Christian Fynbo Christiansen, Marie Linder, Shahram Bahmanyar, Mette Nørgaard, MD PhD, Laurent Sailler, MD PhD, Maryse Lapeyre-Mestre, MD PhD

Blood (2018) 132 (Supplement 1): 3745.

https://doi.org/10.1182/blood-2018-99-112506

Published: 2018

Journal Articles

Hypertension Development, Management, and Cardiovascular Events Following Ibrutinib Initiation for Hematologic Malignancies

Tyler Dickerson, PharmD, Tracy Wiczer, Allyson Waller, Jennifer Philippon, Devin Haddad, Avirup Guha, Kyle Porter, Kerry A. Rogers, MD, Jennifer A. Woyach, MD, John C. Byrd, MD, Daniel Addison, Farrukh T. Awan, MD MS

Blood (2018) 132 (Supplement 1): 4423.

https://doi.org/10.1182/blood-2018-99-110345

Published: 2018

Journal Articles

Clinical Associations, Treatment, and Outcomes of Renal-Limited Thrombotic Microangiopathy

Elias Simon Saba, BS, Julia Claire Cambron, BS, Ronald S. Go, MD, Nelson Leung, MD, Meera Sridharan, MD

Blood (2018) 132 (Supplement 1): 4978.

https://doi.org/10.1182/blood-2018-99-117723

Published: 2018

Journal Articles

Characterization of Cardiovascular Adverse Events and B-Type Natriuretic Peptide Levels in Patients with Multiple Myeloma Who Are Treated with Carfilzomib

Hang Quach, MDFRACP,FRCPA,MBBS, Khue Minh Nguyen, Matthew Ku, MBBS, FRACP, FRCPA, Ali Bazargan, MBBS FRACP FRCPA, Robin J Filshie, PhDFRACP,FRCPA, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Lisa Catherine Demosthenous, MPH, BSN, David Prior, MBBS FRACP PhD

Blood (2018) 132 (Supplement 1): 1956.

https://doi.org/10.1182/blood-2018-99-113802

Published: 2018

Journal Articles

Real Life Evaluation of Efficacy and Safety of Bosutinib Therapy in Chronic Myeloid Leukemia Patients

Blood (2018) 132 (Supplement 1): 3021.

https://doi.org/10.1182/blood-2018-99-113427

Published: 2018

Journal Articles

Prevalence of Cardiovascular Risk Factors and Incidence of Venous and Arterial Thrombosis in Non-Splenectomized Immune Thrombocytopenia Adult Patients in Sweden and France. Results from Two Nationwide Studies

Charlotta Ekstrand, Bérangère Baricault, Marie Linder, Margaux Lafaurie, Laurent Sailler, Maryse Lapeyre-Mestre, Helle Kieler, Shahram Bahmanyar, Guillaume Moulis, MD

Blood (2017) 130 (Supplement 1): 1040.

https://doi.org/10.1182/blood.V130.Suppl_1.1040.1040

Published: 2017

Journal Articles

A Case of Immunotactoid Glomerulopathy (ITG) Associated with Monoclonal B-Cell Lymphocytosis (MBL) with Chronic Lymphocytic Leukemia (CLL) Phenotype Treated with Obinutuzumab

Nino Aleksidze, MD, Michael B Stokes, MD, Alan P Skarbnik, MD

Blood (2017) 130 (Supplement 1): 5324.

https://doi.org/10.1182/blood.V130.Suppl_1.5324.5324

Published: 2017

Journal Articles

The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)— a Study of the European Leukemianet-Based MDS (EUMDS) Registry

Blood (2017) 130 (Supplement 1): 4264.

https://doi.org/10.1182/blood.V130.Suppl_1.4264.4264

Published: 2017

Journal Articles

A Real Life Evaluation of Efficacy and Safety of Ponatinib Therapy in CML Patients

Luigia Luciano, MD, Giorgina Specchia, MD, Bruno Martino, Vincenzo Accurso, MD, Marco Santoro, MD, Alessandra Malato, MD, Nicola Sgherza, Michele Pizzuti, MD, Fabio Stagno, MD PhD, Pellegrino Musto, MD, Attilio Guarini, MD, Fiorenza De Gregorio, MD, Santina Basile, MD, Fabrizio Pane, MD

Blood (2017) 130 (Supplement 1): 2905.

https://doi.org/10.1182/blood.V130.Suppl_1.2905.2905

Published: 2017

Journal Articles

Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma

Blood (2017) 130 (Supplement 1): 1843.

https://doi.org/10.1182/blood.V130.Suppl_1.1843.1843

Published: 2017

Journal Articles

Hematuria Is Not a Risk Factor for the Hypertension of Hemophilia

Haowei (Linda) Sun, MD, Ming Yang, PhD, Afrah S Sait, MD, Annette Von Drygalski, MD PharmD, Shannon Jackson

Blood (2015) 126 (23): 2301.

https://doi.org/10.1182/blood.V126.23.2301.2301

Published: 2015

Journal Articles

Risk Factors for Cardiac Toxicities Associated with Proteasome Inhibitor Chemotherapy during Treatment of Multiple Myeloma

John H. Chen, Daniel J. Lenihan, MD, Sharon E. Phillips, MSPH, Madan H. Jagasia, Stacey A. Goodman, MD MS, Adetola A. Kassim, MD MS, Shelton L. Lacy, Kevin T. McDonagh, Javid J. Moslehi, MD, Tarsheen K. Sethi, MD MS, David A. Slosky, Oluchi C. Ukaegbu, MD, Robert F. Cornell

Blood (2015) 126 (23): 5363.

https://doi.org/10.1182/blood.V126.23.5363.5363

Published: 2015

Journal Articles

Acute Promyelocytic Leukemia: An Unsual Presentation

Mary Kay Vaske, MD, Adeola Tomi-Olugbodi, MD, Indumathy Varadarajan, MD, J. Steve Hou, MD

Blood (2015) 126 (23): 4977.

https://doi.org/10.1182/blood.V126.23.4977.4977

Published: 2015

Journal Articles

Prevalence of Hypertension, Diabetes, Obesity and Smoking in Patients with Hemophilia Followed at a Single Treatment Center

Kamila Izabela Cisak, MD, Jianmin Pan, PhD, Shesh Nath Rai, PhD, Patricia Ashby, ARNP, Vivek R. Sharma, MD FACP

Blood (2015) 126 (23): 4692.

https://doi.org/10.1182/blood.V126.23.4692.4692

Published: 2015

Journal Articles

Infusion of Pegylated Bovine Carboxyhemoglobin (PEG-COHb) Is Associated with Rapid Reversal of Progressive Acute Chest Syndrome in a Jehovah's Witness Patient with Hemoglobin SC Sickle Cell Disease

Roberta Miyeko Kato, MD, Thomas Hofstra, MD, Herbert J. Meiselman, ScD, Henry Jay Forman, PhD, Abe Abuchowski, PhD, Deven V. Parmar, MD, Thomas D. Coates, MD

Blood (2015) 126 (23): 4541.

https://doi.org/10.1182/blood.V126.23.4541.4541

Published: 2015

Journal Articles

Mortality and Morbidity in 15-Year Survivors of Stem Cell Transplants for Haematological Malignancy

Jack Stuart, Richard Szydlo, PhD, Jane F. Apperley, MD, Jeannie Todd, PhD, Nina Salooja, DM, FRCP, FRCPath

Blood (2015) 126 (23): 4348.

https://doi.org/10.1182/blood.V126.23.4348.4348

Published: 2015

NARROW

Occurrence and Resolution of Anthracycline Cardiotoxicity and Impact on Treatment Outcomes Among Children Treated on the AAML1031 Clinical Trial: A Report from the Children's Oncology Group

To Study the Coagulation Profile Derangements in Metabolic Syndrome

Real-World Experience with Fostamatinib in Patients with Immune Thrombocytopenia at an Academic Medical Center

Carfilzomib-Pomalidomide-Dexamethasone (KPD) in Relapsed/Refractory Multiple Myeloma Patients - an Institutional Retrospective Analysis

Risk Factors of Thrombosis in Adults with Primary Immune Thrombocytopenia. a French Nationwide Cohort Study

Hypertension Development, Management, and Cardiovascular Events Following Ibrutinib Initiation for Hematologic Malignancies

Clinical Associations, Treatment, and Outcomes of Renal-Limited Thrombotic Microangiopathy

Characterization of Cardiovascular Adverse Events and B-Type Natriuretic Peptide Levels in Patients with Multiple Myeloma Who Are Treated with Carfilzomib

Real Life Evaluation of Efficacy and Safety of Bosutinib Therapy in Chronic Myeloid Leukemia Patients

Prevalence of Cardiovascular Risk Factors and Incidence of Venous and Arterial Thrombosis in Non-Splenectomized Immune Thrombocytopenia Adult Patients in Sweden and France. Results from Two Nationwide Studies

A Case of Immunotactoid Glomerulopathy (ITG) Associated with Monoclonal B-Cell Lymphocytosis (MBL) with Chronic Lymphocytic Leukemia (CLL) Phenotype Treated with Obinutuzumab

The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)— a Study of the European Leukemianet-Based MDS (EUMDS) Registry

A Real Life Evaluation of Efficacy and Safety of Ponatinib Therapy in CML Patients

Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma

Hematuria Is Not a Risk Factor for the Hypertension of Hemophilia

Risk Factors for Cardiac Toxicities Associated with Proteasome Inhibitor Chemotherapy during Treatment of Multiple Myeloma

Acute Promyelocytic Leukemia: An Unsual Presentation

Prevalence of Hypertension, Diabetes, Obesity and Smoking in Patients with Hemophilia Followed at a Single Treatment Center

Infusion of Pegylated Bovine Carboxyhemoglobin (PEG-COHb) Is Associated with Rapid Reversal of Progressive Acute Chest Syndrome in a Jehovah's Witness Patient with Hemoglobin SC Sickle Cell Disease

Mortality and Morbidity in 15-Year Survivors of Stem Cell Transplants for Haematological Malignancy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only